Fact CheckerSign in

NCT06798259Active, not recruiting

Autonomic Dysfunction in Patients With Migraine: Cardiovascular and Neurophysiology Assessment

Source: ClinicalTrials.gov · Last updated 29 Jan 2025

Brief summary (registry, in English)

Autonomic dysfunction in patients with migraine: cardiovascular and neurophysiology assessment.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
116 (estimated)
First submitted
7 Jan 2025
Start date
7 Jan 2025
Primary completion date
30 Jul 2025
Lead sponsor
Beni-Suef University
Diseases
Migraine
NCT number
NCT06798259

What you commit to

  • Study type: Observational
  • Planned participants: 116
  • From 7 Jan 2025 to the primary completion date, 30 Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • brain imaging showing structural brain lesions. .medications that could impact autonomic function such as tricyclic antidepressants, anticholinergics, or opioids.
  • Patients with concomitant medical illness causing autonomic dysfunction such as: diabetes, cardiovascular, demyelinating or degenerative neurological disorders.

Other

  • Contraindications for performing the tilt test
  • Pregnant patients.

Who the study is looking for

  • 1.fulfilling ICHD-3 criteria for migraine 2. migraine for at least 3 months.

Age in the registry: 18 years to 50 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Benisuef university hospital
Coordinator of this site? Confirm its status
BenisuefEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.